Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$36.45 - $47.7 $6.02 Million - $7.88 Million
-165,133 Reduced 57.75%
120,814 $5.76 Million
Q1 2024

May 14, 2024

BUY
$42.03 - $53.55 $6.01 Million - $7.66 Million
143,093 Added 100.17%
285,947 $12.4 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $296,049 - $352,271
6,823 Added 5.02%
142,854 $7.23 Million
Q3 2023

Nov 14, 2023

BUY
$38.5 - $47.13 $5.24 Million - $6.41 Million
136,031 New
136,031 $6.17 Million
Q4 2022

Feb 14, 2023

BUY
$37.12 - $46.52 $390,205 - $489,018
10,512 New
10,512 $397,000
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $302,228 - $409,833
9,531 New
9,531 $353,000
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $410,551 - $508,929
-13,740 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $351,881 - $482,274
13,740 New
13,740 $418,000
Q2 2021

Aug 16, 2021

SELL
$34.54 - $47.25 $11 Million - $15.1 Million
-319,539 Closed
0 $0
Q1 2021

May 18, 2021

BUY
$42.51 - $63.78 $13.6 Million - $20.4 Million
319,539 New
319,539 $14.4 Million
Q4 2020

Feb 16, 2021

SELL
$45.3 - $60.27 $196,103 - $260,908
-4,329 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$47.45 - $62.95 $365,934 - $485,470
-7,712 Reduced 64.05%
4,329 $205,000
Q2 2020

Aug 14, 2020

BUY
$46.85 - $61.05 $564,120 - $735,103
12,041 New
12,041 $710,000
Q1 2019

May 15, 2019

SELL
$52.92 - $81.17 $860,585 - $1.32 Million
-16,262 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $705,282 - $968,239
16,262 New
16,262 $879,000
Q2 2018

Aug 15, 2018

SELL
$40.53 - $50.7 $381,833 - $477,644
-9,421 Closed
0 $0
Q1 2018

May 16, 2018

BUY
$44.08 - $55.05 $415,277 - $518,626
9,421 New
9,421 $415,000
Q4 2017

Feb 15, 2018

SELL
$50.3 - $64.39 $249,991 - $320,018
-4,970 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$45.56 - $59.57 $226,433 - $296,062
4,970
4,970 $252,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.53B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.